Take off with Vir Biotechnology Inc (VIR): Get ready for trading

With 1.23 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.1 million shares. The 52-week range on VIR shows that it touched its highest point at $14.45 and its lowest point at $6.56 during that stretch. It currently has a 1-year price target of $32.00. Beta for the stock currently stands at 1.17.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VIR was down-trending over the past week, with a drop of -16.37%, but this was down by -23.18% over a month. Three-month performance surged to 3.94% while six-month performance fell -4.23%. The stock lost -31.72% in the past year, while it has gained 7.90% so far this year. A look at the trailing 12-month EPS for VIR yields -3.83 with Next year EPS estimates of -3.07. For the next quarter, that number is -0.84. This implies an EPS growth rate of 12.16% for this year and 8.71% for next year. EPS is expected to grow by 10.08% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -18.74%.

Float and Shares Shorts:

At present, 136.96 million VIR shares are outstanding with a float of 87.38 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VIR since 10 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$3.66423 being high and -$3.98113 being low. For VIR, this leads to a yearly average estimate of -$3.8821. Based on analyst estimates, the high estimate for the next quarter is -$0.62 and the low estimate is -$1.0. The average estimate for the next quarter is thus -$0.83.

Summary of Insider Activity:

Insiders traded VIR stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.